Sorafenib inhibits MAPK-mediated proliferation in a Barrett's esophageal adenocarcinoma cell line

R. N. Keswani, A. Chumsangsri, R. Mustafi, J. Delgado, E. E W Cohen, Marc Bissonnette*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Sorafenib inhibits MAPK-mediated proliferation in a Barrett's esophageal adenocarcinoma cell line'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science